DK0752847T3 - Ophthalmisk sammensætning med nedsat viskositet - Google Patents

Ophthalmisk sammensætning med nedsat viskositet

Info

Publication number: DK0752847T3
Authority: DK; Denmark
Prior art keywords: amount; pct; weight; viscosity; composition
Prior art date: 1994-03-31

Application number

DK95914362T

Other languages

English (en)

Inventor

Kari Lehmussaari

Timo Reunamaeki

Eija Vartiainen

Olli Oksala

Sakari Alaranta

Esko Pohjala

Original Assignee

Santen Pharmaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-03-31

Filing date

1995-03-29

Publication date

2001-10-22

1995-03-29 Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd

2001-10-22 Application granted granted Critical

2001-10-22 Publication of DK0752847T3 publication Critical patent/DK0752847T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Ophthalmology & Optometry (AREA)
Inorganic Chemistry (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

DK95914362T 1994-03-31 1995-03-29 Ophthalmisk sammensætning med nedsat viskositet DK0752847T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9401108A SE9401108D0 (sv)	1994-03-31	1994-03-31	Ophthalmic composition I
PCT/FI1995/000166 WO1995026711A1 (en)	1994-03-31	1995-03-29	Ophthalmic composition with decreased viscosity

Publications (1)

Publication Number	Publication Date
DK0752847T3 true DK0752847T3 (da)	2001-10-22

Family

ID=20393511

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK95914362T DK0752847T3 (da)	1994-03-31	1995-03-29	Ophthalmisk sammensætning med nedsat viskositet

Country Status (27)

Country	Link
US (1)	US5710182A (da)
EP (1)	EP0752847B1 (da)
JP (1)	JPH10503470A (da)
KR (1)	KR100365914B1 (da)
CN (1)	CN1112918C (da)
AT (1)	ATE202921T1 (da)
AU (1)	AU694497B2 (da)
BG (1)	BG63145B1 (da)
BR (1)	BR9507438A (da)
CA (1)	CA2186734A1 (da)
CZ (1)	CZ290987B6 (da)
DE (2)	DE752847T1 (da)
DK (1)	DK0752847T3 (da)
EE (1)	EE03661B1 (da)
ES (1)	ES2161874T3 (da)
GR (1)	GR3036763T3 (da)
HK (1)	HK1013953A1 (da)
HU (1)	HU223071B1 (da)
MX (1)	MX9603918A (da)
NO (1)	NO314434B1 (da)
PL (1)	PL179433B1 (da)
PT (1)	PT752847E (da)
RO (1)	RO115409B1 (da)
RU (1)	RU2139016C1 (da)
SE (1)	SE9401108D0 (da)
SK (1)	SK280492B6 (da)
WO (1)	WO1995026711A1 (da)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9718568D0 (en)	1997-09-03	1997-11-05	Chauvin Pharmaceuticals Limite	Compositions
WO2000064528A1 (en)	1999-04-28	2000-11-02	Situs Corporation	Drug delivery system
US6852688B2 (en)	2000-03-10	2005-02-08	University Of Florida	Compositions for treating diabetic retinopathy and methods of using same
WO2003072081A1 (en) *	2002-02-22	2003-09-04	Pharmacia Corporation	Ophthalmic formulation with gum system
CA2476935C (en) *	2002-02-22	2013-05-28	Santen Pharmaceutical Co., Ltd.	Drug delivery system for subconjunctival administration of fine particles
US20060039979A1 (en) *	2002-12-04	2006-02-23	Kazuhito Yamada	Drug delivery system using subconjunctival depot
JP2004196787A (ja) *	2002-12-04	2004-07-15	Santen Pharmaceut Co Ltd	結膜下デポによるドラッグデリバリーシステム
AU2004249137B2 (en) *	2003-06-13	2010-03-11	Alcon, Inc.	Ophthalmic compositions containing a synergistic combination of two polymers
US7947295B2 (en) *	2003-06-13	2011-05-24	Alcon, Inc.	Ophthalmic compositions containing a synergistic combination of two polymers
WO2005018608A1 (ja) *	2003-08-20	2005-03-03	Santen Pharmaceutical Co., Ltd.	微粒子テノン嚢下投与ドラッグデリバリーシステム
TWI367098B (en) *	2004-12-23	2012-07-01	Kowa Co	Treating agent for glaucoma
US7862552B2 (en)	2005-05-09	2011-01-04	Boston Scientific Scimed, Inc.	Medical devices for treating urological and uterine conditions
DE102005035986B4 (de) *	2005-07-28	2009-10-15	Bausch & Lomb Incorporated	Steriles tropfbares mehrphasiges emulgatorfreies ophthalmisches Präparat
WO2010024930A2 (en)	2008-08-28	2010-03-04	President And Fellows Of Harvard College	Cortistatin analogues and syntheses therof
EP2383286A1 (en)	2010-04-30	2011-11-02	INSERM (Institut National de la Santé et de la Recherche Médicale)	Methods and compositions for treatment of retinal degenerative diseases
WO2012108489A1 (ja) *	2011-02-10	2012-08-16	参天製薬株式会社	親水性薬物の薬物移行性を改善した水性組成物
US20150038557A1 (en)	2012-02-24	2015-02-05	Inserm (Institut National De La Sante Et De La Recherche Medicale)	Methods and compositions for treatment of retinal degenerative diseases
SG11201605178WA (en)	2013-12-24	2016-07-28	Harvard College	Cortistatin analogues and syntheses and uses thereof
EP3294298A4 (en)	2015-05-08	2018-10-17	President and Fellows of Harvard College	Cortistatin analogues, syntheses, and uses thereof
JP2018521000A (ja)	2015-05-29	2018-08-02	シドネキシス，インク．	Ｄ２ｏで安定化された医薬製剤
EP3316889A4 (en)	2015-07-01	2018-11-14	President and Fellows of Harvard College	Cortistatin analogues and syntheses and uses thereof
AR106018A1 (es)	2015-08-26	2017-12-06	Achillion Pharmaceuticals Inc	Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
ES2908479T3 (es)	2015-08-26	2022-04-29	Achillion Pharmaceuticals Inc	Compuestos para el tratamiento de trastornos inmunitarios e inflamatorios
CN109475756A (zh)	2016-02-17	2019-03-15	儿童医疗中心有限公司	Ffa1(gpr40)作为神经血管生成疾病或病症的治疗标靶
EP3455219A4 (en)	2016-05-10	2019-12-18	C4 Therapeutics, Inc.	AMINE-RELATED C3-GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN REDUCTION
SG11201811491YA (en)	2016-06-27	2019-01-30	Achillion Pharmaceuticals Inc	Quinazoline and indole compounds to treat medical disorders
WO2018033854A1 (en) *	2016-08-15	2018-02-22	Santen Pharmaceutical Co., Ltd.	Ophthalmic composition and a method for treating ocular hypertension and glaucoma
MX2019001877A (es)	2016-08-19	2019-09-13	Orasis Pharmaceuticals Ltd	Composiciones farmaceuticas oftalmicas y usos que se relacionan a las mismas.
CN110603252A (zh)	2017-03-01	2019-12-20	艾其林医药公司	用于治疗医学障碍的芳基、杂芳基和杂环药物化合物
PT3548000T (pt) *	2017-05-11	2021-12-10	Vyluma Inc	Composiões farmacológicas com atropina
CN111902141A (zh)	2018-03-26	2020-11-06	C4医药公司	用于ikaros降解的羟脑苷脂结合剂
JP7538113B2 (ja)	2018-08-20	2024-08-21	アキリオンファーマシューティカルズ，インコーポレーテッド	補体ｄ因子の医学的障害の治療のための医薬化合物
EP3866773B1 (en)	2018-10-16	2024-08-28	Georgia State University Research Foundation, Inc.	Carbon monoxide prodrugs for the treatment of medical disorders
JP2023515073A (ja)	2020-02-20	2023-04-12	アキリオンファーマシューティカルズ，インコーポレーテッド	補体因子ｄ媒介障害の処置用のヘテロアリール化合物
CN115279370B (zh)	2020-03-05	2025-01-10	C4医药公司	用于brd9的靶向降解的化合物
US20240139166A1 (en) *	2021-02-04	2024-05-02	Sydnexis, Inc.	Ophthalmic compositions for presbyopia
EP4088714A1 (en)	2021-05-10	2022-11-16	Warszawskie Zaklady Farmaceutyczne Polfa S.A.	Ophthalmic pharmaceutical composition comprising atropine
EP4088713A1 (en)	2021-05-10	2022-11-16	Warszawskie Zaklady Farmaceutyczne Polfa S.A.	Ophthalmic pharmaceutical composition comprising atropine
CN113786380A (zh) *	2021-09-18	2021-12-14	华北制药股份有限公司	一种硝酸毛果芸香碱眼用凝胶及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6056684B2 (ja) *	1977-11-07	1985-12-11	東興薬品工業株式会社	点眼剤
US5252318A (en) *	1990-06-15	1993-10-12	Allergan, Inc.	Reversible gelation compositions and methods of use
FR2678832B1 (fr) *	1991-07-10	1995-03-17	Europhta Sa Laboratoire	Nouvelles compositions ophtalmiques a resorption amelioree et leurs procedes de preparation.

1994
- 1994-03-31 SE SE9401108A patent/SE9401108D0/xx unknown
1995
- 1995-03-29 EE EE9600120A patent/EE03661B1/xx unknown
- 1995-03-29 KR KR1019960705391A patent/KR100365914B1/ko not_active IP Right Cessation
- 1995-03-29 AT AT95914362T patent/ATE202921T1/de active
- 1995-03-29 SK SK1239-96A patent/SK280492B6/sk not_active IP Right Cessation
- 1995-03-29 US US08/535,037 patent/US5710182A/en not_active Expired - Lifetime
- 1995-03-29 DE DE0752847T patent/DE752847T1/de active Pending
- 1995-03-29 HU HU9602691A patent/HU223071B1/hu active IP Right Grant
- 1995-03-29 RO RO96-01877A patent/RO115409B1/ro unknown
- 1995-03-29 ES ES95914362T patent/ES2161874T3/es not_active Expired - Lifetime
- 1995-03-29 BR BR9507438A patent/BR9507438A/pt not_active IP Right Cessation
- 1995-03-29 EP EP95914362A patent/EP0752847B1/en not_active Expired - Lifetime
- 1995-03-29 WO PCT/FI1995/000166 patent/WO1995026711A1/en active IP Right Grant
- 1995-03-29 DK DK95914362T patent/DK0752847T3/da active
- 1995-03-29 PL PL95316584A patent/PL179433B1/pl unknown
- 1995-03-29 DE DE69521686T patent/DE69521686T2/de not_active Expired - Lifetime
- 1995-03-29 CA CA002186734A patent/CA2186734A1/en not_active Abandoned
- 1995-03-29 PT PT95914362T patent/PT752847E/pt unknown
- 1995-03-29 RU RU96119953A patent/RU2139016C1/ru active
- 1995-03-29 AU AU21389/95A patent/AU694497B2/en not_active Ceased
- 1995-03-29 JP JP7525423A patent/JPH10503470A/ja not_active Ceased
- 1995-03-29 CZ CZ19962865A patent/CZ290987B6/cs not_active IP Right Cessation
- 1995-03-29 CN CN95192185A patent/CN1112918C/zh not_active Expired - Fee Related
- 1995-03-29 MX MX9603918A patent/MX9603918A/es unknown
1996
- 1996-09-27 NO NO19964070A patent/NO314434B1/no not_active IP Right Cessation
- 1996-10-16 BG BG100915A patent/BG63145B1/bg unknown
1998
- 1998-12-23 HK HK98115146A patent/HK1013953A1/xx not_active IP Right Cessation
2001
- 2001-09-28 GR GR20010401621T patent/GR3036763T3/el unknown

Also Published As

Publication number	Publication date
EE9600120A (et)	1997-04-15
MX9603918A (es)	1997-04-30
ATE202921T1 (de)	2001-07-15
HK1013953A1 (en)	1999-09-17
PL316584A1 (en)	1997-01-20
DE752847T1 (de)	1997-09-04
AU694497B2 (en)	1998-07-23
CZ286596A3 (en)	1997-04-16
CN1144477A (zh)	1997-03-05
ES2161874T3 (es)	2001-12-16
RU2139016C1 (ru)	1999-10-10
CN1112918C (zh)	2003-07-02
NO314434B1 (no)	2003-03-24
AU2138995A (en)	1995-10-23
GR3036763T3 (en)	2001-12-31
SE9401108D0 (sv)	1994-03-31
SK123996A3 (en)	1997-06-04
BR9507438A (pt)	1997-09-16
JPH10503470A (ja)	1998-03-31
PT752847E (pt)	2001-12-28
KR100365914B1 (ko)	2003-04-16
WO1995026711A1 (en)	1995-10-12
HU9602691D0 (en)	1996-11-28
KR970702024A (ko)	1997-05-13
CZ290987B6 (cs)	2002-11-13
EP0752847A1 (en)	1997-01-15
CA2186734A1 (en)	1995-10-12
NO964070L (no)	1996-11-28
NO964070D0 (no)	1996-09-27
PL179433B1 (pl)	2000-09-29
DE69521686T2 (de)	2002-04-25
EP0752847B1 (en)	2001-07-11
SK280492B6 (sk)	2000-03-13
BG63145B1 (bg)	2001-05-31
US5710182A (en)	1998-01-20
BG100915A (en)	1997-07-31
DE69521686D1 (de)	2001-08-16
HU223071B1 (hu)	2004-03-01
EE03661B1 (et)	2002-04-15
HUT75666A (en)	1997-05-28
RO115409B1 (ro)	2000-02-28

Publication	Publication Date	Title
DK0752847T3 (da)	2001-10-22	Ophthalmisk sammensætning med nedsat viskositet
SE9401109D0 (sv)	1994-03-31	Opthalmic composition II
US5945121A (en)	1999-08-31	Liposome eye drops
KR960700081A (ko)	1996-01-19	콘택트렌즈 용액 보존 시스템(preservative system for contact lens solutions)
NZ230663A (en)	1991-05-28	Antimicrobial, hypotonic, aqueous contact lens composition
WO1998005365A3 (en)	1998-04-30	Compositions and methods for disinfecting contact lenses and preserving contact lens care products
KR940006575A (ko)	1994-04-25	증가된 안내압 치료를 위한 안구 국소 투여용 약제학적 조성물
DE60012068D1 (de)	2004-08-19	Zusammensetzung mit kontinuierlicher wässeriger Phase, die L-2-Oxothiazolidin- 4-carbonsäure enthält".
WO2009006130A2 (en)	2009-01-08	Salt free hyaluronate ophthalmic solution
JPS6452727A (en)	1989-02-28	Antiallergic eye drop
FI963744L (fi)	1996-09-20	Alennetun viskositeetin omaava oftalminen koostumus
AU2001242398A1 (en)	2001-08-27	Contact lens treating method and composition
JPS6217973B2 (da)	1987-04-21